how is semaglutide produced GLP-1 Treatment Specialist Chemical vs. Recombinant: The Manufacturing

Once-weekly injections of CT-388 led to placebo-adjusted weight loss of 22.5% at 48 weeks, without a weight loss plateau, according to Roches Tuesday announcement

The Centers for Disease Control and Prevention (CDC) recommends setting a weekly weight loss target of reducing your daily calorie intake by 500 calories eatinga balanced diet of whole grains, lean proteins, low fat dairy, fruits, and vegetables limiting added sugars, sodium, saturated and trans fats, and alcohol getting at least 150 minutesweekly of moderate intensity aerobic exercise strength training for at least 2 days weekly sleeping for 7 to 9 hourseach night regularly checking in with a doctor, personal trainer, or registered dietitian Learn more about how to lose weight sustainably

Tirzepatide is formulated to mimic the function of native GIP at the GIPR while also interacting with the GLP1R in a manner different from native GLP1

PE, HC, and MJL reviewed and revised the manuscript